Loading stock data...

MedPlus Health Services Limited

NSE: MEDPLUS BSE: MEDPLUS

NSE
731.85 7.50 (1.04%)

Prev Close

724.35

Open Price

719.4

Volume

50,499

Today Low / High

719.35 / 734.3

52 WK Low / High

616 / 875.65

Range

695 - 768

BSE
731.05 7.20 (0.99%)

Prev Close

723.85

Open Price

720

Volume

722

Today Low / High

720 / 734.75

52 WK Low / High

615.55 / 876.75

Range

694 - 768

The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 731.85 (target range: 695 - 768), reflecting a change of 7.5 (1.03541%). On the BSE, it is listed at 731.05 (target range: 694 - 768), showing a change of 7.2 (0.99468%). Both the NSE and BSE data indicate positive movement, suggesting the stock is on an upward trend. This could be an attractive opportunity for investors looking for growth.

04 Mar 719.40 2.24%
03 Mar 712.60 1.65%
28 Feb 720.50 -0.82%
27 Feb 713.00 1.15%
25 Feb 720.40 -0.15%
24 Feb 715.00 1.68%
21 Feb 745.55 -3.05%
20 Feb 749.75 -0.73%
19 Feb 733.00 2.49%
18 Feb 726.00 1.89%
17 Feb 718.10 1.09%
14 Feb 740.10 -2.08%
13 Feb 730.00 2.04%
12 Feb 766.20 -4.28%
11 Feb 771.00 -1.14%
10 Feb 794.75 -2.59%
07 Feb 816.00 -2.42%
06 Feb 794.60 2.15%
05 Feb 775.40 1.93%
04 Feb 769.95 -0.18%

MedPlus Health Services Limited Graph

MedPlus Health Services Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking Target Price for MedPlus Health Services Limited T1, T2, T3, for both Bullish or Bearish. For Bullish T1, T2, T3 and for Bearish T1, T2, T3. The stock current price is 732, with potential price targets ranging from T1, T2, T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 731.05 738.36 664.52 - 812.20
745.67 596.54 - 894.81
752.98 527.09 - 978.88
Bearish Scenario 731.05 723.74 651.37 - 796.11
716.43 573.14 - 859.71
709.12 496.38 - 921.85

Overview of MedPlus Health Services Limited

ISIN

INE804L01022

Industry

Medical - Pharmaceuticals

Vol.Avg

242,170

Market Cap

88,471,694,445

Last Dividend

0

Official Website

Visit Website

IPO Date

2021-12-23

DCF Diff

934.81

DCF

-210

Financial Ratios Every Investor Needs

Stock Rating Details for MEDPLUS

Metric Value Recommendation
Overall Rating D+ Strong Sell
DCF Score 1 Strong Sell
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2024-03-31 5,624.86 Cr 4,410.52 Cr 1,214.34 Cr 0.2159 0.00 Cr 625.62 Cr 563.51 Cr 65.47 Cr 5.48 394.09 Cr 0.0116
2023-03-31 4,557.58 Cr 3,557.69 Cr 999.89 Cr 0.2194 0.00 Cr 20.95 Cr 96.09 Cr 49.76 Cr 4.17 311.75 Cr 0.0109
2022-03-31 3,755.38 Cr 2,982.38 Cr 773.00 Cr 0.2058 0.00 Cr 16.88 Cr 162.71 Cr 95.80 Cr 15.97 303.73 Cr 0.0255
2021-03-31 3,050.78 Cr 2,425.03 Cr 625.75 Cr 0.2051 0.21 Cr 14.16 Cr 135.32 Cr 63.86 Cr 6.26 238.21 Cr 0.0209
2020-03-31 2,851.25 Cr 2,337.79 Cr 513.47 Cr 0.1801 0.25 Cr 10.94 Cr 96.78 Cr 2.18 Cr 1.05 150.96 Cr 0.0008

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2024-03-31 91.21 Cr 3,004.80 Cr 1,427.44 Cr 1,577.9320 Cr 1,009.57 Cr 918.36 Cr 1,340.23 Cr 1,202.69 Cr 15.77 Cr 0.00 Cr 5.10 Cr 525.9350 Cr
2023-03-31 228.38 Cr 2,796.72 Cr 1,306.22 Cr 1,491.1780 Cr 899.92 Cr 671.55 Cr 1,144.09 Cr 1,114.44 Cr 103.18 Cr 0.00 Cr 2.21 Cr 476.5830 Cr
2022-03-31 21.46 Cr 2,594.05 Cr 1,176.80 Cr 1,417.7720 Cr 814.94 Cr 793.48 Cr 914.98 Cr 771.48 Cr 85.33 Cr 0.00 Cr -598.94 Cr 559.0120 Cr
2021-03-31 106.82 Cr 1,565.66 Cr 834.55 Cr 730.5530 Cr 590.21 Cr 483.40 Cr 749.96 Cr 477.58 Cr 71.04 Cr 0.00 Cr -42.28 Cr 414.9400 Cr
2020-03-31 113.92 Cr 1,348.70 Cr 819.59 Cr 527.8020 Cr 477.29 Cr 363.37 Cr 643.56 Cr 379.00 Cr 82.01 Cr 0.00 Cr -26.78 Cr 481.0860 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2024-03-31 143.7370 Cr -82.7990 Cr -198.1040 Cr 59.3380 Cr -137.1660 Cr 91.2090 Cr -84.3990 Cr 65.4730 Cr 0.0000 Cr 0.0000 Cr -196.1470 Cr
2023-03-31 90.4100 Cr 429.4410 Cr -170.2490 Cr -78.5950 Cr 349.6020 Cr 228.3750 Cr -169.0050 Cr 47.1630 Cr -88.4110 Cr 0.0000 Cr -229.1030 Cr
2022-03-31 169.8890 Cr -703.1260 Cr 440.4290 Cr 52.1680 Cr -92.8080 Cr -121.2270 Cr -117.7210 Cr 117.9430 Cr -65.6380 Cr 0.0000 Cr -165.0270 Cr
2021-03-31 2.8910 Cr -34.5490 Cr -5.6260 Cr -51.3670 Cr -37.2840 Cr -28.4190 Cr -54.2580 Cr 95.0980 Cr 0.0000 Cr 0.0000 Cr -106.4020 Cr
2020-03-31 -6.5890 Cr -27.5540 Cr 89.8270 Cr -36.8000 Cr 55.6840 Cr 8.8640 Cr -30.2110 Cr 29.3590 Cr -32.5000 Cr 0.0000 Cr -249.4890 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2024-12-31 1,561.45 Cr 1,170.58 Cr 390.86 Cr 0.2503 0.00 Cr 45.89 Cr 3.84 145.04 Cr 0.0294
2024-09-30 1,576.17 Cr 1,201.87 Cr 374.30 Cr 0.2375 61.30 Cr 38.74 Cr 3.24 136.04 Cr 0.0246
2024-06-30 1,488.83 Cr 1,381.42 Cr 107.40 Cr 0.0721 167.43 Cr 14.36 Cr 1.20 93.76 Cr 0.0096
2024-03-31 1,490.50 Cr 1,373.71 Cr 116.79 Cr 0.0784 46.65 Cr 33.40 Cr 2.81 116.33 Cr 0.0224
2023-12-31 1,441.47 Cr 1,122.74 Cr 318.73 Cr 0.2211 44.46 Cr 13.73 Cr 1.15 101.57 Cr 0.0095

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2024-09-30 123.97 Cr 179.09 Cr 303.07 Cr 0.00 Cr 1,340.71 Cr 1,712.39 Cr 1,190.99 Cr 3,155.07 Cr 1,519.40 Cr
2024-06-30 0.00 Cr 0.00 Cr 174.24 Cr 0.00 Cr 0.00 Cr 174.24 Cr 0.00 Cr 0.00 Cr -1,577.36 Cr
2024-03-31 141.68 Cr 83.03 Cr 141.68 Cr 17.50 Cr 1,340.23 Cr 1,567.55 Cr 1,201.38 Cr 3,004.80 Cr 1,427.44 Cr
2023-12-31 198.59 Cr 392.10 Cr 198.59 Cr 0.00 Cr 1,317.19 Cr 1,586.91 Cr 1,171.46 Cr 2,978.45 Cr 1,432.64 Cr
2023-09-30 120.38 Cr 107.76 Cr 228.14 Cr 8.83 Cr 1,274.92 Cr 1,561.36 Cr 1,158.07 Cr 2,937.41 Cr 1,415.43 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2024-06-30 14.36 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-03-31 33.40 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2023-12-31 13.73 Cr 114.22 Cr 0.00 Cr 0.00 Cr 78.21 Cr 198.59 Cr 120.38 Cr 0.00 Cr 114.22 Cr
2023-09-30 14.56 Cr 110.95 Cr 0.00 Cr 0.00 Cr -129.54 Cr 120.38 Cr 249.92 Cr 0.00 Cr 110.95 Cr
2023-06-30 3.79 Cr 104.83 Cr 0.00 Cr 0.00 Cr 21.55 Cr 249.92 Cr 228.38 Cr 0.00 Cr 104.83 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Pharmaceuticals

Company Name Symbol Price Market Cap Volume
MedPlus Health Services Limited MEDPLUS ₹731.85 ₹87,597,929,486.00 ₹50,499.00

Key Executives

Chief Strategy Officer
Mr. Chetan Dikshit

Gender: male

Year Born:

Founder, Chief Executive Officer, MD & Chairman
Dr. Gangadi Madhukar Reddy

Gender: Not Specified

Year Born: 1967

Chief Operating Officer & Whole Time Director
Dr. Cherukupalli Bhaskar Reddy

Gender: Not Specified

Year Born:

Chief Financial Officer
Mr. Sujit Kumar Mahato

Gender: male

Year Born:

Chief Technology Officer
Mr. Venugopal Siripuram

Gender: male

Year Born:

Head of Corporate Secretarial & Governance, Company Secretary and Compliance Officer
Mr. Manoj Kumar Srivastava

Gender: male

Year Born:

Head of Supply Chain
Mr. Kandasamy Vairaperumal

Gender: male

Year Born:

FAQs about MedPlus Health Services Limited

Who is the CEO of the company?

The CEO is Dr. Gangadi Madhukar Reddy.

What is the current market price of the stock?

The current price is ₹739.15.

What is the 52-week price range?

The range is ₹616-875.65.

What is the market capitalization of the company?

The market capitalization is ₹8,847.17 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 66.72.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of MedPlus Health Services Limited (ISIN: INE804L01022) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹8,847.17 crores and an average daily volume of 242,170 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.

Welcome to the Investing and Trading Information platform: InvesTrack.in

Note: This platform is for educational and informational purposes only. Do not consider anything as financial advice.

QUICK LINKS

Home
About us
Contact us
Privacy Policy
Disclaimer
Sitemap
Investing
Trading
Top Brokers
Tools
Live Analysis

STAY CONNECTED

Follow Us On Social Media
Get Latest Update On Social Media
Facebook Instagram Twitter

General Disclaimer: InvesTrack is an educational platform and not any type of investment advisory platform. Our Blog and videos are based on countless hours of research and experience, which you can use as a guide for your research purposes. None of our content should be considered a piece of investment advice. Earning Disclosure: InvesTrack is a community supported platform. We may earn a commission when you make a purchase through one of our links at no extra cost to you. Note: We are not SEBI Registered Advisors. This website is purely for training and educational purposes. We shall not be responsible for your profit or loss.

© Copyright 2024 - 2025 | InvesTrack